Sun. Dec 4th, 2022

Fxtriangle | Market analysis | Managed trading

Fxtriangle will make Fx trading look easy.

China grants its first covid vaccine patent to CanSino

2 min read

China’s vaccine maker CanSino Biologics Inc has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, People’s Daily reported, citing documents from the country’s intellectual property regulator. The patent was submitted for application on March 18, and was approved on August 11, the report said. It is the first COVID-19 vaccine patent granted by China.

CanSino’s vaccine uses a modified common cold virus to carry genetic material from the new coronavirus into the human body, a method also used by the Oxford/AstraZeneca vaccine.

Both vaccines elicited antibody and T-cell immune responses and neither prompted any serious side effects in early trials. T-cells are an important component of the immune system’s attack against foreign invaders, such as viruses.

Results of both trials were released in the medical journal the Lancet.

Reports said that CanSino’s covid vaccine has already received the greenlight to be used by China’s military despite not yet undergoing the type of large-scale testing needed to prove its ability to prevent infection.

CanSino’s vaccine candidate was the first in China to move into human testing in March but other potential vaccines developed by Sinovac Biotech and a unit of China National Pharmaceutical Group (Sinopharm) have already been approved for Phase III trials overseas.

Saudi Arabia said this month it plans to begin Phase III clinical trials for the CanSino vaccine. CanSino has said it is also in talks with Brazil and Chile to launch Phase III trials in those countries.

Leave a Reply

Forex trading and any instruments related to Foreign Exchange Market are Speculative and carry substantial risk of loss of either partial equity or the entire deposit amount. Leverage adds up to the risk, before considering to invest in this venture, you should first consider your financial position and may seek the help of an independent financial advisor. FXtriangle dis-recommends the usage of loan instruments to trade in this market as it can hamper financial position. Please do not invest the money that you cannot afford to lose. FXtriangle provides all its services throughout the Globe Excluding (Nigeria, British Virgin Island & the Islamic Republic of Iran) and also provides limited service in some jurisdictions where investment in Overseas markets / Fx Exchanges are prohibited by Law If you are not sure to contact us before using any of our services. FXtriangle acts as an Independent Corporate Financial Advisor and connects you to various overseas exchanges and cannot be held liable for any financial damage occurring through their side. All of our partnered institutions are regulated in various jurisdictions.FXtriangle conducts an independent background check before partnering with any institutions to fulfill your investment objectives smoothly. The usage of our Business name, Logo or any trademark in any financial forum, website, review website, complaint arena, Billboards without our written permission will attract lawsuits.